In advanced prostate cancer, strong CK8 expression with weak or absent CK5/6 expression is typically observed, whereas AR—a hormone receptor—remains highly expressed and is characteristic of prostatic adenocarcinomas. Here, KRT5 is linked to prostate carcinoma.